Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Long-term elimination of hepatitis C virus from human hepatocyte chimeric mice after interferon-γ gene transfer.

Takahashi Y, Ando M, Nishikawa M, Hiraga N, Imamura M, Chayama K, Takakura Y.

Hum Gene Ther Clin Dev. 2014 Mar;25(1):28-39. doi: 10.1089/humc.2013.066. Epub 2013 Dec 28.

PMID:
24279674
2.

Liver-directed gamma interferon gene delivery in chronic hepatitis C.

Shin EC, Protzer U, Untergasser A, Feinstone SM, Rice CM, Hasselschwert D, Rehermann B.

J Virol. 2005 Nov;79(21):13412-20.

3.

Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.

Watanabe T, Sugauchi F, Tanaka Y, Matsuura K, Yatsuhashi H, Murakami S, Iijima S, Iio E, Sugiyama M, Shimada T, Kakuni M, Kohara M, Mizokami M.

Gut. 2013 Sep;62(9):1340-6. doi: 10.1136/gutjnl-2012-302553. Epub 2012 Nov 7.

4.

ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.

Abe H, Imamura M, Hiraga N, Tsuge M, Mitsui F, Kawaoka T, Takahashi S, Ochi H, Maekawa T, Hayes CN, Tateno C, Yoshizato K, Murakami S, Yamashita N, Matsuhira T, Asai K, Chayama K.

J Hepatol. 2011 Jul;55(1):11-8. doi: 10.1016/j.jhep.2010.10.017. Epub 2010 Nov 29.

PMID:
21145867
5.

Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.

Chang KO, George DW.

J Virol. 2007 Sep;81(18):9633-40. Epub 2007 Jul 3.

6.

Removal of transgene-expressing cells by a specific immune response induced by sustained transgene expression.

Yin Y, Takahashi Y, Ebisuura N, Nishikawa M, Takakura Y.

J Gene Med. 2014 Mar-Apr;16(3-4):97-106. doi: 10.1002/jgm.2763.

PMID:
24807854
7.
8.

Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes.

Suzuki K, Aoki K, Ohnami S, Yoshida K, Kazui T, Kato N, Inoue K, Kohara M, Yoshida T.

Biochem Biophys Res Commun. 2003 Aug 8;307(4):814-9.

PMID:
12878183
9.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

10.

Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes.

Kan Q, Li D, Yu Z.

J Virol Methods. 2012 Mar;180(1-2):84-90. doi: 10.1016/j.jviromet.2011.12.016. Epub 2012 Jan 5.

PMID:
22240074
12.

Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin.

Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Hsieh MY, Wang LY, Yu ML.

Antiviral Res. 2005 Aug;67(2):93-7.

PMID:
16051377
13.

Long-term pegylated interferon monotherapy following 72 weeks of pegylated interferon and ribavirin in hepatitis C virus genotype-1-infected slow responders.

Watanabe S, Kobayashi Y, Kawata K, Noritake H, Chida T, Nagasawa M, Kageyama F, Kawamura K, Sasada Y, Suda T.

Intern Med. 2015;54(3):273-9. doi: 10.2169/internalmedicine.54.2718.

14.

Improved anti-cancer effect of interferon gene transfer by sustained expression using CpG-reduced plasmid DNA.

Kawano H, Nishikawa M, Mitsui M, Takahashi Y, Kako K, Yamaoka K, Watanabe Y, Takakura Y.

Int J Cancer. 2007 Jul 15;121(2):401-6.

15.

Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies.

Soriano V, Maida I, Núñez M, García-Samaniego J, Barreiro P, Martín-Carbonero L, González-Lahoz J.

Antivir Ther. 2004 Dec;9(6):987-92.

PMID:
15651757
16.
17.

Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.

Gunduz F, Mallikarjun C, Balart LA, Dash S.

Exp Mol Pathol. 2014 Feb;96(1):36-41. doi: 10.1016/j.yexmp.2013.10.016. Epub 2013 Nov 8.

18.

Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways.

Young KC, Bai CH, Su HC, Tsai PJ, Pu CY, Liao CS, Lin YM, Lai HW, Chong LW, Tsai YS, Tsao CW.

Antiviral Res. 2014 Oct;110:158-67. doi: 10.1016/j.antiviral.2014.08.002. Epub 2014 Aug 21.

PMID:
25151487
19.

Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Sep-Oct;157(5):457-68. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):208.

PMID:
17147054
20.

Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.

Zeuzem S, Schmidt JM, Lee JH, Rüster B, Roth WK.

Hepatology. 1996 Feb;23(2):366-71.

PMID:
8591865
Items per page

Supplemental Content

Write to the Help Desk